Novartis Investigative Site
Warwick, Rhode Island 02886
0 studies enrolling now · 4 studies all time
What they study most
Acute Heart Failure, Cardiovascular Disease, Chronic Obstructive Pulmonary Disease (COPD), Heart Failure With Preserved Ejection Fraction, Type 2 Diabetes Mellitus
Studies at this site
- Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fraction — Completed
- Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF — Completed
- Long Term Safety Study of NVA237 vs QAB149 in COPD Patients — Completed
- Aliskiren Trial in Type 2 Diabetes Using Cardiovascular and Renal Disease Endpoints (Core and Extension Phases) — Stopped early